H.R. 5202 · 115th Congress
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
CostelloSponsor7 cosponsors · 1 D, 6 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
What it does: CRS summary · Introduced in House · Mar 7, 2018
Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump.
The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018
Latest action (May 9, 2018): Ordered to be Reported by Voice Vote.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Mar 7, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.